← Every company
Krystal Biotech Inc Patents
What Krystal Biotech Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
KRYS on carbonthat →Filings on file
14
Granted
0
Still pending
14
Filed under
3 names
14 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| Compositions and Methods for the Treatment of ATPase Disorders or Diseases of the SkinC12N 15/86, A61P 17/00, A61K 35/763, A61K 38/43, A61K 48/005, A61K 48/0075, C12N 9/14, C12N2710/16643, A61K2300/00Filed as Krystal Biotech. Inc.2026-03-26Suma Krishnan | pending |
| Compositions and Methods for Delivering CFTR PolypeptidesC07K 14/4712, C12N 15/86, A61P 11/06, A61P 11/10, A61P 1/18, A61P 11/00, A61P 11/02, A61K 9/0073, A61K 9/0075, A61K 9/0078, A61K 38/1709, A61K 48/00, A61K 48/0075, C07K 14/4702, C12N 7/00, C12N2710/16011, C12N2710/16041, C12N2710/16043, C12N2710/16071, C12N2710/16111, C12N2710/16511, C12N2710/16611, C12N2710/16621, C12N2710/16622, C12N2710/16632, C12N2710/16643, C12N2710/16671, C12N2710/16711Filed as Krystal Biotech, Inc.2025-12-10Trevor Parry | pending |
| Compositions and Methods for the Treatment of ATPase Disorders or Diseases of the SkinC12N 15/86, A61P 17/00, A61K 35/763, A61K 38/43, A61K 48/005, A61K 48/0075, C12N 9/14, C12N2710/16643, A61K2300/00Filed as Krystal Biotech, Inc.2025-11-03Suma Krishnan | pending |
| Interleukin-2 and Interleukin-12 for Cancer TherapyA61K 48/005, A61P 35/00, A61K 38/2013, A61K 38/208, A61K 48/0033, A61K 48/0041, A61K 48/0075Filed as KRYSTAL BIOTECH, INC.2025-09-02Suma Krishnan | pending |
| Viral Vectors for Cancer TherapyA61K 35/763, A61K 48/0066, C12N 15/86, A61P 35/00, A61K 38/193, A61K 38/195, A61K 38/2013, A61K 38/208, C07K 14/5434, C07K 14/55, C12N 7/00, C12N2710/16622, C12N2710/16633, C12N2710/16643, C12N2710/16662, C12N2710/16671Filed as Krystal Biotech, Inc.2025-06-11Suma Krishnan | pending |
| Compositions and Methods for the Treatment of Congenital IchthyosesC12N 15/86, A61P 17/00, C07K 14/47, C12N 15/8695, C12N2710/16643, C12N2710/16671Filed as Krystal Biotech, Inc.2025-05-21Suma Krishnan | pending |
| Viral Vectors for Cosmetic AdministrationFiled as Krystal Biotech, Inc.2025-01-21Suma Krishnan | pending |
| Compositions and Methods for the Treatment of ATPase Disorders or Diseases of the SkinFiled as Krystal Biotech, Inc.2024-11-01Suma Krishnan | pending |
| Recombinant Nucleic Acids Encoding Cosmetic Protein(s) For Aesthetic ApplicationsA61K 8/65, A61K 8/99, A61Q 19/08, C12N 15/86, A61P 17/04, A61K 8/64, A61K 9/0019, A61K 35/763, A61K 38/39, A61K 48/005, A61K2800/86, A61K2800/91, A61Q 19/00, C07K 14/78, C12N2710/16043, C12N2710/16621, C12N2710/16631Filed as Krystal Biotech, Inc.2024-09-25Suma Krishnan | pending |
| Compositions and Methods for Gene Delivery to the Airways and/or LungsC12N 15/86, A61P 11/00, A01K2227/105, A01K2227/106, A61K 9/0078, A61K 38/1709, A61K 38/57, A61K 48/00, A61K 48/005, A61M 11/005, C07K 14/8125, C12N 7/00, C12N2710/00043, C12N2710/00071, C12N2710/16643Filed as Krystal Biotech, Inc.2024-09-13Suma Krishnan | pending |
| Methods and Compositions for Treating Conditions Involving the EyeA61K 38/185, A61K 48/0033, C12N 15/86, A61P 27/02, A01K2217/075, A01K2227/105, A01K2267/0306, A61K 48/005, A61K 48/0075, C07K 14/475, C12N 9/00, C12N2710/16622, C12N2710/16643, C12N2710/16652, C12N2710/16662Filed as Krystal Biotech, Inc.2024-09-10Suma Krishnan | pending |
| Methods and Compositions for Treating Conditions Involving the EyeA61K 38/185, A61K 48/0033, C12N 15/86, A61P 27/02, A01K2217/075, A01K2227/105, A01K2267/0306, A61K 48/005, A61K 48/0075, C07K 14/475, C12N 9/00, C12N2710/16622, C12N2710/16643, C12N2710/16652, C12N2710/16662Filed as Krystal Biotech, Inc.2024-04-12Suma Krishnan | pending |
| INTERLEUKIN-2 AND INTERLEUKIN-12 FOR CANCER THERAPYFiled as KRYSTAL BIOTECH, INC.2024-03-01SUMA KRISHNAN | pending |
| Viral Vectors for Cancer TherapyA61K 35/763, A61K 48/0066, C12N 15/86, A61P 35/00, A61K 38/193, A61K 38/195, A61K 38/2013, A61K 38/208, C07K 14/5434, C07K 14/55, C12N 7/00, C12N2710/16622, C12N2710/16633, C12N2710/16643, C12N2710/16662, C12N2710/16671Filed as Krystal Biotech, Inc.2024-01-09Suma Krishnan | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on KRYS
Company overviewEverything on KRYS in one place, with the price.SEC filingsWhat KRYS's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat KRYS's own officers and directors buy and sell.Who owns itEvery manager reporting a position in KRYS.Funds holding itWhich funds and ETFs hold KRYS, and how big a bet.